Novo Nordisk Down, GSK Departure, Lufthansa Up

Stock Movers

On this episode of Stock Movers:

- Novo Nordisk fell as Morgan Stanley downgraded its rating to underweight on weaker prescription momentum for the firm’s weight-loss drugs.

- GSK CEO Emma Walmsley is stepping down after almost nine years with chief commercial officer Luke Miels taking over on January 1st.

- Lufthansa gained after the airline outlined new financial goals, including plans to cut 4,000 administrative jobs by 2030.

See omnystudio.com/listener for privacy information.

2025-09-29 4 min Transcript

Available Results

Generated results are saved to your library for reuse and search.

No generated results are available for this episode yet.

Transcript

Open the Transcript tab to load the transcript.

Chapters

No chapters available.